Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species. (28th August 2013)

• Record Type: Journal Article
• Authors: Manuja, Anju; Manuja, Balvinder K.; Kaushik, Jyoti; Singha, Harisankar; Singh, Raj Kumar
• Is Part Of: Immunopharmacology and immunotoxicology. Volume 35:Number 5(2013:Oct.)
• Page Start: 535
• Page End: 544
• Publication Date: 2013-08-28
• Subjects: Animal -- CpG -- immunotherapeutic -- infectious diseases -- TLR9; Immunopharmacology -- Periodicals; Immunotoxicology -- Periodicals; Antibody-toxin conjugates -- Periodicals; Immunology -- Periodicals; 615.37
• DOI: 10.3109/08923973.2013.828743
• Languages: English
• ISSNs: 0892-3973

Abstract

Abstract: Innate immunity plays a critical role in host defense against infectious diseases by discriminating between self and infectious non-self. The recognition of infectious non-self involves germ-line encoded pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs). The PAMPs are the components of pathogenic microbes which include not only the cell wall constituents but also the unmethylated 2′-deoxy-ribo-cytosine-phosphate-guanosine (CpG) motifs. These CpG motifs present within bacterial and viral DNA are recognized by toll-like receptor 9 (TLR9), and signaling by this receptor triggers a proinflammatory cytokine response which, in turn, influences both innate and adaptive immune responses. The activation of TLR9 with synthetic CpG oligodeoxynucleotides (ODNs) induces powerful Th1-like immune responses. It has been shown to provide protection against infectious diseases, allergy and cancer in laboratory animal models and some domestic animal species. With better understanding of the basic biology and immune mechanisms, it would be possible to exploit the potential of CpG motifs for animal welfare. The research developments in the area of CpG and TLR9 and the potential applications in animal health have been reviewed in this article.